Anavex Life Sciences Corp (AVXL)

[drv17]

CTAD embargo policy.
Home
ABOUT CTAD
PROGRAM
LOCATION
REGISTRATIONS
PRESS AND FAQS
SPONSORS
CTAD EMBARGO POLICIES AND FAQS
You are here
You Are Here: Home » CTAD Embargo Policies And FAQs

CTAD Embargo Policies and FAQs
The International Conference on Clinical Trials for Alzheimer’s Disease (CTAD) is an annual conference organized and planned by Alzheimer’s disease clinical researchers to share scientific information with each other. The 9th annual CTAD will be held December 8-10 in San Diego, CA - USA.

Credentialed members of the media are allowed to receive a free registration to the conference. To request your free pass to CTAD 2016 please contact Benedicte CLEMENT at [e-mail].

When are abstracts available?

All embargoed abstracts will be made available on December 8 at 8 a.m. PT at www.ctad-alzheimer.com. Our embargo policies are strictly enforced. All research is embargoed until the date/time that it is shared at a CTAD presentation, symposia or poster session. After the abstract presentation, you may publish/write on the abstract content.

Can I discuss CTAD abstract content before the embargo lifts?

Presentation or discussion of embargoed content at satellite meetings or press conferences before the CTAD embargo lifts is prohibited.

CTAD-Alzheimer | 8th Clinical Trials on Alzheimer’s Disease 
 www.ctad-alzheimer.com